Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung disease
Biotech
Brii punts HIV, depression, lung programs to potential partners
Brii Biosciences is going on all in on hepatitis B, hoping potential partners will show interest in the rest of its wide-ranging pipeline.
James Waldron
Mar 22, 2024 11:34am
Insilico 'pulls back the curtain' in paper on AI drug discovery
Mar 8, 2024 5:00am
AN2's stock craters as lead lung disease phase 3 trial paused
Feb 12, 2024 8:16am
Vertex drops lung therapy, rethinks DMD drug's path to clinic
Nov 7, 2023 6:00am
BMS charts 2nd pulmonary fibrosis win with LPA1 antagonist
Sep 11, 2023 10:05am
Meitheal pays Xentria $45M for right to TNF drug in lung disease
Jun 27, 2023 6:00am